1 min read

The Wolves of Chernobyl Are Evolving Resistance to Cancer

Wolves in a radioactive no-man's land are thriving at seven times normal density. Their genomes show cancer-resistance adaptations no lab has ever produced.

Thirty-eight years after a nuclear reactor exploded and rendered 1,000 square miles of Ukraine and Belarus uninhabitable, the gray wolves living inside that irradiated perimeter are not merely surviving. They appear to be evolving it away. The fastest-changing regions of their genome sit in and around genes involved in cancer immune response and antitumor activity in mammals.

Evolutionary biologist Cara Love of Princeton University has been studying these wolves for a decade. Her team entered the exclusion zone in 2014, radio-collared animals and collected blood samples, and by pairing wolf movement data with radiation sensors they could track exactly how much exposure each animal was accumulating in real time. Radiation levels inside the zone run at 11.28 millirem, six times the permitted occupational exposure for workers.

As apex predators, these wolves absorb radiation at every level of the food chain: irradiated soil, plants, prey. The textbook prediction would be population collapse. Instead, wolf density in the exclusion zone is seven times higher than in protected reserves just across the border.

Love found that Chernobyl wolves have altered immune systems resembling those of cancer patients undergoing radiation treatment, and she has identified specific genomic regions that appear resilient to increased cancer risk. Most human cancer research identifies mutations that raise risk; Love's work aims to map the ones that improve survival odds.

The ongoing war in Ukraine has made it nearly impossible for the team to return to the exclusion zone, which is, all things considered, the most human sentence in this entire story.

The wolves have been working on this problem for four decades. They didn't wait for us to figure it out.

Read the full story at Popular Mechanics, January 23, 2026


Hot Take: The wolves have been running an uncontrolled cancer adaptation trial for four decades, with no IRB approval, no grant cycle, and no corresponding author. They are further along than we are.

Subscribe to our newsletter.

Be the first to know - subscribe today